Close

Dynavax (DVAX) Reports FDA Advisory Committee Vote in Favor of HEPLISAV-B

July 28, 2017 4:36 PM EDT Send to a Friend
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login